Skip to main content

Hogge Gary S.'s Form 4 filing

Lineage Cell Therapeutics, Inc. (LCTX) · filed Dec 30, 2021

Accession no.
0001493152-21-032897
Filed
Dec 30, 2021
Trade date
Dec 28-29, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 7 non-derivative transactions and 4 derivative transactions. Open-market sales total $1.32M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hogge Gary S.CIK 0001771711Officer (SVP,Clinical & Medical Affairs)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 28, 2021Common Shares, no par valueMOption exerciseAcquired+185,000$0.69+$127,650213,445Direct
Dec 28, 2021Common Shares, no par valueMOption exerciseAcquired+236,899$2.11+$499,856.89450,344Direct
Dec 28, 2021Common Shares, no par valueMOption exerciseAcquired+79,689$1.14+$90,845.46530,033Direct
Dec 28, 2021Common Shares, no par valueSSaleDisposed−501,588$2.45−$1,228,890.628,445Direct
Dec 29, 2021Common Shares, no par valueMOption exerciseAcquired+9,250$0.69+$6,382.537,695Direct
Dec 29, 2021Common Shares, no par valueSSaleDisposed−9,250$2.49−$23,032.528,445Direct
Dec 29, 2021Common Shares, no par valueSSaleDisposed−28,445$2.44−$69,405.80Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 28, 2021Common SharesMOption exerciseDisposed−185,000$0.00$0259,000Direct
Dec 28, 2021Common SharesMOption exerciseDisposed−236,899$0.00$010,301Direct
Dec 28, 2021Common SharesMOption exerciseDisposed−79,689$0.00$032,811Direct
Dec 29, 2021Common SharesMOption exerciseDisposed−9,250$0.00$0249,750Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)